CM
GMED icon

Castleark Management’s Globus Medical GMED Stock Holding History

Castleark Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83,220
Closed -$6.09M – 302
2025
Q1 		$6.09M Buy
83,220
+1,890
+2% +$156K 0.21% 95
2024
Q4 		$6.73M Sell
81,330
-3,450
-4% -$272K 0.23% 95
2024
Q3 		$6.07M Buy
84,780
+41,140
+94% +$2.9M 0.25% 97
2024
Q2 		$2.99M Buy
+43,640
New +$2.61M 0.12% 154
2021
Q4 		– Sell
-18,590
Closed -$1.42M – 344
2021
Q3 		$1.42M Buy
+18,590
New +$1.49M 0.05% 208
2014
Q4 		– Sell
-322,174
Closed -$8.57M – 362
2014
Q3 		$8.57M Sell
322,174
-27,400
-8% -$564K 0.24% 87
2014
Q2 		$8.36M Buy
349,574
+27,400
+9% +$661K 0.23% 99
2014
Q1 		$8.57M Buy
+322,174
New +$7.66M 0.24% 87

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Castleark Management's GMED Position: Q2 2025 in Review

Castleark Management sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 83,220 shares — an estimated $6.09M sold.

Castleark Management first reported a position in GMED in Q1 2014 and held it in 8 quarters. The position peaked at $8.57M in Q3 2014. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Castleark Management reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Castleark Management sold 83,220 Globus Medical shares in Q2 2025, an estimated $6.09M.
  • Castleark Management first reported a position in Globus Medical in Q1 2014 and held it in 8 quarters.
  • Castleark Management's Globus Medical position peaked at $8.57M in Q3 2014.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Castleark Management's 13F filing for Q2 2025, filed 18 Aug 2025.